Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: Comparison to adult patients

References

• Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4–12.
   PubMed Web of Science ®Google Scholar
• Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004;114:831–7.
   PubMed Web of Science ®Google Scholar
• Andre C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229–34.
   PubMed Web of Science ®Google Scholar
• Baena-Cagnani CE, Passalacqua G, Baena-Cagnani RC, Croce VH, Canonica WG. Sublingual immunotherapy in pediatric patients: beyond clinical efficacy. Curr Opin Allergy Clin Immunol 2005;5:173–7.
   PubMed Web of Science ®Google Scholar
• Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160–6.
   PubMed Web of Science ®Google Scholar
• Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167–73.
   PubMed Web of Science ®Google Scholar
• Ferres J, Justicia JL, Garcia MP, Munoz-Tuduri M, Alva V. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice. Allergol Immunopathol (Madr) 2011;39:122–7.
   PubMed Web of Science ®Google Scholar
• Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazawa T, Nakano A, Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children. Allergol Int 2010;59:381–8.
   PubMedGoogle Scholar
• Chang H, Han DH, Mo JH, Kim JW, Kim DY, Lee CH, Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol 2009;2:136–40.
   PubMed Web of Science ®Google Scholar
• Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results. Am J Rhinol Allergy 2010;24:271–5.
   PubMed Web of Science ®Google Scholar
• Hirsch T, Sahn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8:21–7.
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001;32:49–55.
   PubMed Web of Science ®Google Scholar
• Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy 2007;62:954–7.
   PubMed Web of Science ®Google Scholar
• Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498–504.
   PubMed Web of Science ®Google Scholar
• Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004;59:1285–93.
   PubMed Web of Science ®Google Scholar
• Guez S, Vatrinet C, Fadel R, Andre C. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369–75.
   PubMed Web of Science ®Google Scholar
• Nuhoglu Y, Ozumut SS, Ozdemir C, Ozdemir M, Nuhoglu C, Erguven M. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period. J Investig Allergol Clin Immunol 2007;17:375–8.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Mansueto P, Pacor ML, Rizzo M, Castello F, Martinelli N, Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol 2009;123:1103–10; 10 e1–4.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147–334.
   PubMed Web of Science ®Google Scholar
• Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021–35.
   PubMed Web of Science ®Google Scholar
• Marogna M, Bruno M, Massolo A, Falagiani P. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life. Int Arch Allergy Immunol 2007;142:70–8.
   PubMed Web of Science ®Google Scholar